Author | Terry L. Evans, MD | OncLive

Author | Terry L. Evans, MD

Articles

Dr. Evans on the Tolerability of CDK4/6 Inhibitors in HR+ Breast Cancer

November 09, 2018

Video

Terry L. Evans, MD, clinical assistant professor of medicine, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, discusses the tolerability of CDK4/6 inhibitors in hormone receptor (HR)-positive breast cancer.

x